Not checked for notices yet.
Emergence of BCR–ABL1 Fusion in AML Post–FLT3 Inhibitor-Based Therapy: A Potentially Targetable Mechanism of Resistance – A Case Series
Ahmad S. Alotaibi, Musa Yilmaz, Sanam Loghavi and 12 more
Frontiers in Oncology · 2020
Cited by papers we hold 1
- FLT3 mutated acute myeloid leukemia: 2021 treatment algorithm · 2021No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.